Evaluation of a new vessel imaging system to support venous cannulation in children.
- Conditions
- venous cannulation, venipuncture, near-infrared, vessel visualization, VascuLuminator.Veneuze cannulatie, infuus, venapunctie, infrarood licht, vaat imaging, VascuLuminator
- Registration Number
- NL-OMON27154
- Lead Sponsor
- MC Utrecht
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
All consecutive patients aged less than 18 years, referred to the pediatric anesthesiologist for venipuncuture or intravenous cannulation, will be included in the present trial.
Exclusion Criteria
If a patient needs two cannulas placed at the same moment, the second puncture will be excluded (since the best place is already occupied with the first cannula).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is the percentage of procedures in which more than one puncture is required for successful venous cannulation or venipuncture (i.e. failure rate).
- Secondary Outcome Measures
Name Time Method Secondary parameters will be the number of punctures and the duration of the procedure. The duration of the procedure starts at the moment the first attempt is made to search for a suitable vessel, by palpating or looking (with the system in use, looking with the system) and ends at the moment the line is flushed, or blood is collected in the tube (in case of a venipuncture). <br /><br>Pain perception by the patient during the puncture will be measured by standardized pain scales; for patients less than 4 years the FLACC (faces, legs, activity, cry and consolability) scale, for patients between 4 and 7 years the Wong – Baker Faces scale, and for children above 7 years of age the VAS (Visual Analogue Scale). <br /><br>Other risk factors for difficult punctures, such as skin color, weigth and length, age, history of frequent puncturing and certain medications or diseases (corticosteroids, chemotherapy, down syndrome, history of frequent puncturing), will be registered. <br>